New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference February 9th
February 05, 2015 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Journal of Cardiovascular Pharmacology Publishes Positive Nonclinical Results of Proteon Therapeutics' PRT-201 in Peripheral Artery Disease
January 08, 2015 16:30 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference December 11th
December 08, 2014 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Third Quarter 2014 Financial Results
November 25, 2014 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces the Closing of Initial Public Offering and the Underwriters' Option to Purchase Additional Shares
November 24, 2014 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the Stifel Nicolaus 2014 Healthcare Conference November 18th
November 17, 2014 08:49 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Pricing of Initial Public Offering
October 21, 2014 19:36 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc., a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and...
Blood Purification Technologies Inc. logo
Blood Purification Technologies Announced That the FDA Approved the First US Trial of the Wearable Artificial Kidney
February 11, 2014 15:09 ET | Blood Purification Technologies Inc.
ATLANTA, Feb. 11, 2014 (GLOBE NEWSWIRE) -- The U.S. Food & Drug Administration has approved the start of the first human clinical trials in the United States for the Wearable Artificial Kidney...
Dialysis: Five Ways to Be Active in Your Care at the Hospital; Joint Commission Launches Speak Up(TM) Brochure on World Kidney Day
March 10, 2011 17:46 ET | The Joint Commission
OAKBROOK TERRACE, IL--(Marketwire - March 10, 2011) - Dialysis patients who find themselves in the emergency department or admitted into the hospital are encouraged to play an active role in managing...